Newsbenzinga
Rapport Therapeutics Announces That Topline Results From Its Phase 2 Trial Of RAP-219 In Adults With Acute Bipolar Mania Met Primary Endpoint
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…